CN Patent

CN102485721B — 取代的2,3-二氮杂萘酮化合物及其用途

Assigned to Cao Ya · Expires 2015-12-09 · 10y expired

What this patent protects

本发明涉及取代的2，3-二氮杂萘酮类化合物、该类化合物及其异构体、盐、溶剂化物、化学保护的形式和前药等的制备、以及它们用于抑制聚腺苷二磷酸核糖聚合酶活性以及和抑制聚腺苷二磷酸核糖聚合酶活性相关的包括但不限于抗肿瘤药物用途。

USPTO Abstract

本发明涉及取代的2，3-二氮杂萘酮类化合物、该类化合物及其异构体、盐、溶剂化物、化学保护的形式和前药等的制备、以及它们用于抑制聚腺苷二磷酸核糖聚合酶活性以及和抑制聚腺苷二磷酸核糖聚合酶活性相关的包括但不限于抗肿瘤药物用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN102485721B
Jurisdiction
CN
Classification
—
Expires
2015-12-09
Drug substance claim
No
Drug product claim
No
Assignee
Cao Ya
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.